Iovance Biotherapeutics, Inc. - Common Stock - relatórios financeiros (NASDAQ:IOVA) | MetaTrader

Abrir gráfico completo Full chart

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer.

Notícias

IBRX Stock Outlook After Q1 Results and a New FDA Review

ImmunityBio: Anktiva Explained and What Comes Next

AGEN vs. IOVA: Which Cancer Biotech Stock Has More Upside Potential?

Juros a descoberto da Intellia lideram alta entre biotechs, diz Baird

IOVA Q1 Earnings Match Estimates, Sales Miss, Stock Down 13%

Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Lags Revenue Estimates

Resultados da Iovance em foco: vendas do Amtagvi superam desafios de produção?

Alvotech (ALVO) Reports Q1 Loss, Lags Revenue Estimates

Ultragenyx (RARE) Reports Q1 Loss, Misses Revenue Estimates

Undercovered Stocks: Western Digital, SAP, Toast And More

Pacira (PCRX) Q1 Earnings Miss Estimates

Iovance Biotherapeutics (IOVA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release